UnitedHealth Group Inc (NYSE:UNH) – Investment analysts at Jefferies Group boosted their Q1 2018 EPS estimates for shares of UnitedHealth Group in a research note issued to investors on Tuesday. Jefferies Group analyst D. Windley now expects that the healthcare conglomerate will earn $2.99 per share for the quarter, up from their previous estimate of $2.90. Jefferies Group has a “Buy” rating and a $248.00 price target on the stock. Jefferies Group also issued estimates for UnitedHealth Group’s Q2 2018 earnings at $2.97 EPS, Q3 2018 earnings at $3.17 EPS, Q4 2018 earnings at $3.44 EPS, FY2018 earnings at $12.56 EPS and FY2019 earnings at $14.41 EPS.
Several other brokerages have also issued reports on UNH. Argus lifted their target price on shares of UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research report on Thursday. Deutsche Bank lifted their target price on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday. Citigroup lifted their target price on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research report on Wednesday. Piper Jaffray Companies reiterated a “buy” rating and set a $259.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Finally, Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $269.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $241.30.
Shares of UnitedHealth Group (NYSE UNH) traded up $4.73 during trading on Thursday, reaching $243.16. 6,234,000 shares of the company’s stock traded hands, compared to its average volume of 3,634,767. UnitedHealth Group has a twelve month low of $156.49 and a twelve month high of $243.90. The company has a market capitalization of $234,630.00, a price-to-earnings ratio of 22.70, a PEG ratio of 1.45 and a beta of 0.66. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same period in the previous year, the business posted $2.11 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis.
A number of institutional investors have recently modified their holdings of UNH. Capital International Investors increased its position in UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares during the period. Jennison Associates LLC grew its position in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after buying an additional 3,289,470 shares during the period. Janus Henderson Group PLC grew its position in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after buying an additional 2,264,242 shares during the period. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after buying an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC grew its position in shares of UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after buying an additional 1,562,661 shares during the period. 86.09% of the stock is currently owned by institutional investors and hedge funds.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,655 shares of company stock worth $7,469,083. 0.89% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.